BIOMAT Database Logo BIOMAT Database Logo

The mechanism of discordant xenograft rejection. 1989

S Miyagawa, and H Hirose, and R Shirakura, and S Nakata, and Y Naka, and S Kitagawa, and S Nakano, and M Matsumoto, and T Seya, and H Kitamura
First Department of Surgery, Osaka University Medical School, Japan.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006386 Hemagglutination Tests Sensitive tests to measure certain antigens, antibodies, or viruses, using their ability to agglutinate certain erythrocytes. (From Stedman, 26th ed) Hemagglutination Test,Test, Hemagglutination,Tests, Hemagglutination
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

S Miyagawa, and H Hirose, and R Shirakura, and S Nakata, and Y Naka, and S Kitagawa, and S Nakano, and M Matsumoto, and T Seya, and H Kitamura
Discordant lung xenograft rejection in the rat.
January 1992, Transplantation,
S Miyagawa, and H Hirose, and R Shirakura, and S Nakata, and Y Naka, and S Kitagawa, and S Nakano, and M Matsumoto, and T Seya, and H Kitamura
In vivo and in vitro study of hyperacute rejection mechanism of renal discordant xenograft.
February 1991, Transplantation proceedings,
S Miyagawa, and H Hirose, and R Shirakura, and S Nakata, and Y Naka, and S Kitagawa, and S Nakano, and M Matsumoto, and T Seya, and H Kitamura
Discordant xenograft rejection in an antibody-free model.
October 1992, Transplantation,
S Miyagawa, and H Hirose, and R Shirakura, and S Nakata, and Y Naka, and S Kitagawa, and S Nakano, and M Matsumoto, and T Seya, and H Kitamura
Immunobiology of discordant xenograft rejection and potential therapeutic modalities.
June 1996, Transplantation proceedings,
S Miyagawa, and H Hirose, and R Shirakura, and S Nakata, and Y Naka, and S Kitagawa, and S Nakano, and M Matsumoto, and T Seya, and H Kitamura
Characteristics of corneal xenograft rejection in a discordant species combination.
July 1993, Investigative ophthalmology & visual science,
S Miyagawa, and H Hirose, and R Shirakura, and S Nakata, and Y Naka, and S Kitagawa, and S Nakano, and M Matsumoto, and T Seya, and H Kitamura
Discordant complement systems as a factor in hyperacute xenograft rejection.
April 1992, Transplantation proceedings,
S Miyagawa, and H Hirose, and R Shirakura, and S Nakata, and Y Naka, and S Kitagawa, and S Nakano, and M Matsumoto, and T Seya, and H Kitamura
Hyperacute rejection of renal discordant xenograft (pig-to-rabbit): model assessment and rejection mechanisms.
June 1990, Transplantation proceedings,
S Miyagawa, and H Hirose, and R Shirakura, and S Nakata, and Y Naka, and S Kitagawa, and S Nakano, and M Matsumoto, and T Seya, and H Kitamura
Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection.
November 1994, Transplantation,
S Miyagawa, and H Hirose, and R Shirakura, and S Nakata, and Y Naka, and S Kitagawa, and S Nakano, and M Matsumoto, and T Seya, and H Kitamura
Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model.
June 1998, The Journal of thoracic and cardiovascular surgery,
S Miyagawa, and H Hirose, and R Shirakura, and S Nakata, and Y Naka, and S Kitagawa, and S Nakano, and M Matsumoto, and T Seya, and H Kitamura
Characteristics of xenograft. II. Cytostatic effector mechanism for xenograft rejection.
April 1981, The Japanese journal of experimental medicine,
Copied contents to your clipboard!